Träningstoleranstest
Granskad av Dr Doug McKechnie, MRCGPSenast uppdaterad av Dr Philippa Vincent, MRCGPSenast uppdaterad 29 Apr 2025
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av vårdpersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kan hitta Träningstoleranstest artikel mer användbar, eller en av våra andra hälsoartiklar.
Synonyms: include exercise ECG testing, treadmill testing, exercise stress test
What is exercise tolerance testing?
Exercise tolerance testing (ETT) is one method which is used to determine the presence of significant coronary heart disease. Chest pain is a common presentation both to general practitioners and to A&E departments.1 Often one of the differentials is cardiac chest pain; ruling this out in patients who might be otherwise well or who have few cardiac risk factors, can be difficult.
ETT has been quoted as having a sensitivity of 78% and a specificity of 70% in detecting coronary artery disease (CAD).2 Thus, a negative test may not necessarily be true and further testing or advice may be warranted. Diagnostic accuracy has previously been thought to be poor in women, possible due to smaller heart size.3 More recent studies suggest that the previous assumption of poor diagnostic accuracy (based on normal coronary angiograms following a positive stress test) may also be due to ischaemia with no obstructive coronary artery disease (INOCA), which is more common in women. INOCA occurs when there are structural or functional abnormalities of the coronary vasculature, such as microvascular dysfunction or coronary artery spasm. 4
ETT has been being superseded by cardiac imaging techniques, such as myocardial perfusion scans, in some centres. Even so, ETT can be valuable when performed in selected patients and the following criteria have been suggested:5
Ability to exercise.
Normal baseline 12-lead ECG.
No previous cardiac revascularisation.
Indications for exercise tolerance testing
Diagnosis of coronary heart disease (keeping in mind the high number of false positives and false negatives).
Assessment of 'fitness' in certain occupations and medical condition - for example, the police force and some cardiomyopathies.
Arrhythmias - ETT can help to record arrhythmias which are provoked by exercise (but only in those with non-life-threatening arrhythmias).
Most patients with suspected angina were traditionally referred for exercise ECG testing. Exercise ECG testing has a relatively high sensitivity but only moderate specificity for the diagnosis of CAD. A normal exercise test may reassure many patients but it does not exclude a diagnosis of CAD.6
The 2010 National Institute for Health and Care Excellence (NICE) guidance for patients presenting with chest pain recommends that exercise ECG should not be used to diagnose or exclude stable angina for people without known CAD.7
The NICE guidance also states that, for people with confirmed CAD (eg, previous myocardial infarction, revascularisation, previous angiography), non-invasive functional testing should be offered when there is uncertainty about whether chest pain is caused by myocardial ischaemia, and that exercise ECG may be used instead of functional imaging.7
What the exercise tolerance test involves
ETT consists of exercising on a treadmill following a defined protocol, the Bruce protocol, over approximately 20 minutes. The test begins gently and gradually the level of intensity is increased through a combination of increased treadmill speed and incline.
Intensity of exercise is measured in metabolic equivalents (METs) where 1 MET is the amount of energy expended at rest or 3.5 ml oxygen per kilogram per minute.
The test is divided into seven stages of three minutes and there is also a less strenuous version called the modified Bruce.
ECG is recorded throughout and blood pressure measured intermittently.
ETT might be prematurely stopped for any of the following: development of chest pain, presence of ST elevation, very deep, 2 mm or more ST depression, arrhythmias, hypotension or if the patient becomes tired and is unable to continue. In addition, elevation of blood pressure to dangerous levels such as >250/115 mm Hg should also lead to termination of the test.
Beta-blockers and digoxin can interfere with the results so are usually stopped before the ETT.
Contra-indications to exercise tolerance testing
Chest pain at rest or at night.
Any condition where left ventricular output is reduced - for example, aortic stenosis or hypertrophic obstructive cardiomyopathy (HOCM).
Active systemic illness.
Abnormal baseline ECG (for example, bundle branch block patterns or left ventricular hypertrophy); these make interpretation of the ETT difficult.
Suspected or confirmed life-threatening arrhythmias.
Interpreting the exercise tolerance test
ST elevation - usually this will be picked up straightaway and dealt with.
The patient is normally considered to have been adequately 'stressed' if they achieve 85% or more of their maximum heart rate (calculated as 220 - age in years for men and 210 - age for women). However, recent data suggest that using these criteria to terminate the test may lead to an underestimation of inducible ischaemia.8
At each stage each lead should be examined for:
Planar ST depression (this can be difficult to delineate from depression of the J point, which is the point where the QRS complex meets the ST wave).
'Flipping' of the T waves.
Arrhythmias.
Examination of all leads should continue into the recovery stage after the exercise stage of the test has been completed.
Complications of exercise tolerance testing
These are rare but can be fatal - for example, myocardial infarction, left ventricular rupture, ventricular fibrillation or ventricular tachycardia.
Following up an abnormal exercise tolerance test
Cardiologists will normally investigate further if an adequate ETT was undertaken and is abnormal.
If an inadequate test was performed, further non-invasive investigations may be indicated, such as myocardial perfusion scanning, cardiac MRI, or stress echocardiogram. Again these will be organised by cardiologists.
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Vilcant V, Zeltser R; Treadmill Stress Testing
- Fitzgerald P, Goodacre SW, Cross E, et al; Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial. Acad Emerg Med. 2011 May;18(5):488-95. doi: 10.1111/j.1553-2712.2011.01068.x.
- Megnien JL, Simon A; Exercise tolerance test for predicting coronary heart disease in asymptomatic individuals: A review. Atherosclerosis. 2009 Aug;205(2):579-83. Epub 2008 Dec 31.
- Siegler JC, Rehman S, Bhumireddy GP, et al; The accuracy of the electrocardiogram during exercise stress test based on heart size. PLoS One. 2011;6(8):e23044. Epub 2011 Aug 17.
- Rethinking the Goal of Exercise Tolerance Testing: Identifying Ischemic Heart Disease, Whether Epicardial or Microvascular; Journal of the American College of Cardiology
- Miller TD; Stress testing: the case for the standard treadmill test. Curr Opin Cardiol. 2011 Sep;26(5):363-9.
- Management of stable angina; Scottish Intercollegiate Guidelines Network - SIGN (April 2018)
- Bröstsmärta av nyligen debut; NICE Klinisk Riktlinje (Mars 2010, uppdaterad Nov 2016)
- Jain M, Nkonde C, Lin BA, et al; 85% of maximal age-predicted heart rate is not a valid endpoint for exercise treadmill testing. J Nucl Cardiol. 2011 Dec;18(6):1026-35. Epub 2011 Sep 16.
Om författarenVisa fullständig biografi

Dr Philippa Vincent, MRCGP
Allmänläkare, Medicinsk Författare
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent är en NHS-läkare som arbetar i norra London.
Om recensentenVisa fullständig biografi

Dr Doug McKechnie, MRCGP
Medicinsk skribent
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Dr Doug McKechnie är en NHS-läkare som arbetar i London. Han arbetar kliniskt på heltid och är också biträdande ansvarig för modulen Klinisk och Professionell Praxis vid University College London Medical School.
Artikelhistorik
Informationen på denna sida är skriven och granskad av kvalificerade kliniker.
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Next review due: 28 Apr 2028
29 Apr 2025 | Senaste versionen

Fråga, dela, anslut.
Bläddra i diskussioner, ställ frågor och dela erfarenheter inom hundratals hälsorelaterade ämnen.

Känner du dig sjuk?
Bedöm dina symtom online gratis
Mer om historia och undersökning
- Akut urinretention
- Graviditetsundersökningar och diagnos av graviditet
- Dyspareunia
- Guillain-Barrés syndrom
- Halitos
- Hyperventilering
- Hypnagogiska hallucinationer
- Sjuk och febrig barn
- Klumpar
- Narkolepsi och kataplexi
- Neurologisk undersökning av de nedre extremiteterna
- Bestående illamående eller kräkningar
- Postinflammatorisk hypopigmentering av huden
- Proctalgia fugax och anal smärta
- Psykiatrisk bedömning
- Axelundersökning
- Subkonjunktival blödning
- Yrsel
- Svårigheter att tömma blåsan